Cargando…

Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways

Hepatocellular carcinoma (HCC) is a significant health problem worldwide with poor prognosis. Drug repositioning represents a profitable strategy to accelerate drug discovery in the treatment of HCC. In this study, we developed a new approach for predicting therapeutic drugs for HCC based on tissue-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Liang, Wang, Meng, Yang, Yang, Xu, Fengdan, Zhang, Xu, Xie, Fei, Gao, Lin, Li, Xiangzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920387/ https://www.ncbi.nlm.nih.gov/pubmed/33561121 http://dx.doi.org/10.1371/journal.pcbi.1008696

Ejemplares similares

Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression
por: Yu, Liang, et al.
Publicado: (2020)

Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α
por: Wang, Meng, et al.
Publicado: (2021)

Tissue factor pathway inhibitor-2 induced hepatocellular carcinoma cell differentiation
por: Li, Ziwei, et al.
Publicado: (2017)

A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses
por: Cai, Guangzhen, et al.
Publicado: (2022)

Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
por: Li, Hu, et al.
Publicado: (2023)

Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
por: Yao, Min, et al.
Publicado: (2022)

Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets Discovery
por: Zhao, Qianwei, et al.
Publicado: (2020)

EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma
por: Gao, Xiaqing, et al.
Publicado: (2023)

Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma
por: Ye, Fengdan, et al.
Publicado: (2018)

Suppressing ERK Pathway Impairs Glycochenodeoxycholate-Mediated Survival and Drug-Resistance in Hepatocellular Carcinoma Cells
por: Li, Bingxin, et al.
Publicado: (2021)

Identification and Comparison of Differentiation-Related Proteins in Hepatocellular Carcinoma Tissues by Proteomics
por: Zhao, Sheng, et al.
Publicado: (2017)

Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
por: Chen, Qinjunjie, et al.
Publicado: (2020)

Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
por: Dimri, Manali, et al.
Publicado: (2020)

Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma
por: Yuan, Weiwei, et al.
Publicado: (2023)

Immune-related lincRNA pairs predict prognosis and therapeutic response in hepatocellular carcinoma
por: Zhang, Yingna, et al.
Publicado: (2022)

Comparison of single-nucleus and single-cell transcriptomes in hepatocellular carcinoma tissue
por: Wen, Fei, et al.
Publicado: (2022)

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma
por: Song, Fei, et al.
Publicado: (2023)

Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity
por: Yu, Liang, et al.
Publicado: (2018)

Non-coding RNA in drug resistance of hepatocellular carcinoma
por: Ding, Bisha, et al.
Publicado: (2018)

Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
por: Qiu, Jun, et al.
Publicado: (2023)

Predicting hepatocellular carcinoma through cross-talk genes identified by risk pathways
por: Liu, Lei, et al.
Publicado: (2018)

Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma
por: Sang, Liang, et al.
Publicado: (2018)

Preoperative Assessment of Abdominal Adipose Tissue to Predict Microvascular Invasion in Small Hepatocellular Carcinoma
por: Wu, Zongqian, et al.
Publicado: (2022)

Overactivated neddylation pathway in human hepatocellular carcinoma
por: Yu, Jian, et al.
Publicado: (2018)

A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)

DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma
por: Lu, Chang-Yi, et al.
Publicado: (2023)

ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2022)

Genetic variants of cell cycle pathway genes predict disease‐free survival of hepatocellular carcinoma
por: Liu, Shun, et al.
Publicado: (2017)

RASAL3 predicts overall survival and CD8+ T lymphocyte infiltration in lung adenocarcinoma
por: Liang, Mei, et al.
Publicado: (2022)

RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma
por: Zhang, Jian, et al.
Publicado: (2014)

Gentamicin promoted the production of CD4(+)CD25(+) Tregs via the STAT5 signaling pathway in mice sepsis
por: Li, Jinfeng, et al.
Publicado: (2022)

Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma
por: Li, Chengzhang, et al.
Publicado: (2020)

The Histone Acetyltransferase MOF Regulates SIRT1 Expression to Suppress Renal Cell Carcinoma Progression
por: Guo, Renbo, et al.
Publicado: (2022)

Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis
por: Xu, Junxiu, et al.
Publicado: (2023)

Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside
por: Guan, Ming-Cheng, et al.
Publicado: (2021)

Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)

Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses
por: Yin, Liang-Chun, et al.
Publicado: (2018)

The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
por: Zhao, Siqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1pv84oojvsmvq50espk7vlsoj1